Savara ( ($SVRA) ) just unveiled an update. On October 29, 2025, Savara Inc. announced the pricing of a $130 million public offering of common ...
The market is rapidly advancing, driven by the demand for smaller, more powerful batteries for wearable and remote monitoring ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...